DXP (DXPE) Q1 2026 Earnings Call Transcript

DXP Enterprises reported Q1 revenue of $521.7 million, up 9.5% year over year, with adjusted EBITDA of $57.8 million and adjusted diluted EPS of $1.26. Gross margin improved 79 bps to 32.3% and free cash flow was $26.3 million, while liquidity remained strong at $366.7 million despite higher SG&A and some one-time costs. Management said January was unexpectedly soft but bookings improved through March and April, and it remains active on M&A with three acquisitions closed and five more in the pipeline.

Analysis

The core signal here is not “steady growth” but a re-acceleration profile after a weak opening month, which matters because this business is levered to conversion timing and project releases rather than pure end-demand. That creates a cleaner setup for margin expansion into the next 1-2 quarters if the current cadence holds: fixed-cost absorption should improve as the revenue run-rate normalizes, while the quarter already showed that mix is shifting toward higher-value engineered content. The market is likely underappreciating how much of the earnings bridge is self-help versus macro, making the next print sensitive to sustained daily-sales momentum more than headline quarterly growth.

The second-order winner is the acquisition platform itself. With liquidity still ample and leverage manageable, the company can keep buying fragmented water, pump, and MRO assets into a stronger distribution/engineering footprint; that should widen its moat in local service response and shorten quote-to-cash cycles, which directly supports margin. The risk is that integration complexity and working-capital drag rise faster than synergies, especially if the acquired book skews toward lower-quality receivables or longer project cycles in water, which would cap free cash flow conversion even if reported sales stay healthy.

The hidden bearish angle is that the “January mystery” may be an early warning on cyclicality in otherwise resilient end markets. If industrial demand is merely delayed rather than improved, the quarter-end surge could be a timing artifact that pulls revenue forward and leaves the next 30-60 days vulnerable to a digestion phase. That said, the business appears better positioned than consensus assumes because backlog, backlog mix, and M&A are reinforcing each other rather than competing for capital, which reduces the probability of a sharp deceleration absent a broader industrial slowdown.

For now, this looks like a quality compounder with a catalyst path through margin realization and acquisition contribution, not a momentum name. The asymmetric opportunity is to own it through the next 1-2 quarters while sentiment is still anchored to the January miss, then reassess only if average daily sales flatten or SG&A fails to normalize.

Key Decisions for Investors

• Long DXPE outright on any post-earnings consolidation; target a 1-2 quarter hold for margin leverage and acquisition close-through, with downside primarily tied to a reversal in daily-sales momentum.
• Buy DXPE call spreads 3-6 months out to express upside from operating leverage while limiting risk if the January softness proves transitory and the stock rerates on a cleaner Q2/Q3 cadence.
• Pair trade: long DXPE / short a more cyclically exposed industrial distributor or MRO name with less mix shift and weaker balance-sheet flexibility; thesis is DXPE’s self-help should outpace peers over the next 2 quarters.
• Avoid chasing after a strong open; wait for any 5-8% pullback or a two-day post-earnings fade, since the setup is more about confirmation of cadence than immediate headline surprise.